The early identification of early choroidal neovascularization (CNV) signs in patients with pathologic myopia or MFC is key to optimize the final visual outcome by prompting intravitreal injection of vascular endothelial growth factor (VEGF) inhibitors. The gene discussed is VEGFA; the disease is choroidal neovascularization.